266 related articles for article (PubMed ID: 29977661)
1. Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature.
Wirtschafter E; VanBeek C; Linhares Y
Exp Hematol Oncol; 2018; 7():14. PubMed ID: 29977661
[TBL] [Abstract][Full Text] [Related]
2. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature.
Mirza AS; Verma S; Fu L; Bassil C
J Hematol; 2017 Sep; 6(2-3):52-58. PubMed ID: 32300393
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Successful Treatment With Anti-C5 Monoclonal Antibody in a Japanese Adolescent Who Developed Thrombotic Microangiopathy After Autologous Bone Marrow Transplantation for Malignant Lymphoma.
Shimizu S; Morohashi T; Kanezawa K; Yagasaki H; Takahashi S; Morioka I
Front Pediatr; 2022; 10():908183. PubMed ID: 35859949
[TBL] [Abstract][Full Text] [Related]
5. Narsoplimab for severe transplant-associated thrombotic microangiopathy.
Pandrowala A; Ganatra P; Krishnan VP; Sharma AN; Chavan S; Bodhanwala M; Agarwal B; Hiwarkar P
Thromb J; 2023 Mar; 21(1):26. PubMed ID: 36915123
[TBL] [Abstract][Full Text] [Related]
6. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
8. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.
Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA
Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840
[TBL] [Abstract][Full Text] [Related]
9. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy.
Karakioulaki M; Martinez M; Medinger M; Heim D; Passweg JR; Tsakiris DA
Int J Lab Hematol; 2020 Apr; 42(2):145-151. PubMed ID: 31769937
[TBL] [Abstract][Full Text] [Related]
11. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
12. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.
Elfeky R; Lucchini G; Lum SH; Ottaviano G; Builes N; Nademi Z; Battersby A; Flood T; Owens S; Cant AJ; Young H; Greener S; Walsh P; Kavanagh D; Annavarapu S; Rao K; Amrolia P; Chiesa R; Worth A; Booth C; Skinner R; Doncheva B; Standing J; Gennery AR; Qasim W; Slatter M; Veys P
Blood Adv; 2020 Jun; 4(11):2418-2429. PubMed ID: 32492158
[TBL] [Abstract][Full Text] [Related]
13. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
14. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management.
Dvorak CC; Higham C; Shimano KA
Front Pediatr; 2019; 7():133. PubMed ID: 31024873
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy].
Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP
Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520
[No Abstract] [Full Text] [Related]
16. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.
Choi CM; Schmaier AH; Snell MR; Lazarus HM
Drugs; 2009; 69(2):183-98. PubMed ID: 19228075
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Schoettler M; Lehmann L; Li A; Ma C; Duncan C
Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
[TBL] [Abstract][Full Text] [Related]
20. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
